Tramadol Hydrochloride is a premium-grade, high-purity active pharmaceutical ingredient (API), manufactured in India by GMP-certified facilities to meet stringent pharmacopoeial standards. Supplied in a hermetically sealed, industrial-grade 25 kg drum, it appears as a white to off-white, bitter, crystalline, odorless powder. It is readily soluble in water and ethanol, ensuring versatile processing capabilities across multiple dosage forms.
Chemically designated as (±)cis-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl) cyclohexanol hydrochloride (C16H25NO2·HCl), it has a molecular weight of 299.8 g/mol (CAS: 36282-47-0).
This API exerts its pain-relieving effect through a unique dual mechanism that provides effective multimodal analgesia:
-
Opioid Agonist Activity: As a centrally acting synthetic opioid analgesic, it functions as a non-selective pure agonist at μ-, δ- and κ-opioid receptors, with a higher affinity for the μ-receptor.
-
Monoamine Reuptake Inhibition: It weakly inhibits the neuronal reuptake of norepinephrine and enhances serotonin release, which contributes synergistically to its analgesic effects.
In human patients, analgesia typically begins within approximately one hour after oral administration and reaches its peak effect within two to three hours.
This high-quality API is a critical raw material for formulating finished pharmaceutical products for a wide variety of severe and chronic pain disorders. Key applications include:
-
Acute Pain Management: A core component in oral tablets and capsules for the management of moderate to moderately severe pain (e.g., post-operative, dental, traumatic, and fracture-related).
-
Chronic Pain Therapy: Used in extended-release formulations for around-the-clock treatment of persistent, moderate to severe pain conditions requiring long-term opioid therapy (e.g., osteoarthritis, chronic back pain, and neuropathic pain).
-
Injectable Formulations: A key ingredient in sterile solutions for injection or infusion, administered for rapid pain relief in hospital and acute care settings.
-
Fixed-Dose Combinations (FDCs): Extensively utilized in the production of combination drugs with non-opioid analgesics such as paracetamol (acetaminophen) or NSAIDs for synergistic and broad-spectrum relief.












